Screener
Sutro Biopharma STRO Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's free cash flow margin?
- Sutro Biopharma (STRO) reported free cash flow margin of -152.2% in Q1 2026.
- How has Sutro Biopharma's free cash flow margin changed year-over-year?
- Sutro Biopharma's free cash flow margin increased by 50.6% year-over-year, from -308.1% to -152.2%.
- What is the long-term trend for Sutro Biopharma's free cash flow margin?
- Over 3 years (2020 to 2025), Sutro Biopharma's free cash flow margin has grown at a 2.6% compound annual growth rate (CAGR), from -160% to -172.9%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Sutro Biopharma's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude